Figure 2From: BAP31, a promising target for the immunotherapy of malignant melanomasExpression profiles of human BAP31 in normal human tissues analyzed by IHC staining. There was marginal immunoreactivity for BAP31 in the lung (A), colon (B) and rectum (C). The brown products in these tissues were restricted to minority of cells. Whereas the skin (D) ovary (E), breast (F), cervix (G) and esophagus (H) were negative for BAP31. Bar: 50 μm.Back to article page